AU5954990A - Production of antigens by self-assembly of polypeptide components - Google Patents

Production of antigens by self-assembly of polypeptide components

Info

Publication number
AU5954990A
AU5954990A AU59549/90A AU5954990A AU5954990A AU 5954990 A AU5954990 A AU 5954990A AU 59549/90 A AU59549/90 A AU 59549/90A AU 5954990 A AU5954990 A AU 5954990A AU 5954990 A AU5954990 A AU 5954990A
Authority
AU
Australia
Prior art keywords
antigens
self
assembly
production
polypeptide components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU59549/90A
Other versions
AU667796B2 (en
Inventor
Timothy John French
Polly Roy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natural Environment Research Council
Sanofi Pasteur Biologics LLC
Original Assignee
Natural Environment Research Council
OraVax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Environment Research Council, OraVax Inc filed Critical Natural Environment Research Council
Publication of AU5954990A publication Critical patent/AU5954990A/en
Assigned to NATURAL ENVIRONMENT RESEARCH COUNCIL, ORAVAX, INC reassignment NATURAL ENVIRONMENT RESEARCH COUNCIL Alteration of Name(s) of Applicant(s) under S113 Assignors: NATURAL ENVIRONMENT RESEARCH COUNCIL, OXFORD VIROLOGY PLC
Application granted granted Critical
Publication of AU667796B2 publication Critical patent/AU667796B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12111—Orbivirus, e.g. bluetongue virus
    • C12N2720/12123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU59549/90A 1989-07-07 1990-07-06 Production of antigens by self-assembly of polypeptide components Ceased AU667796B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898915571A GB8915571D0 (en) 1989-07-07 1989-07-07 Production of antigens by self-assembly of polypeptide components
GB8915571 1989-07-07
PCT/GB1990/001049 WO1991000914A1 (en) 1989-07-07 1990-07-06 Production of antigens by self-assembly of polypeptide components

Publications (2)

Publication Number Publication Date
AU5954990A true AU5954990A (en) 1991-02-06
AU667796B2 AU667796B2 (en) 1996-04-18

Family

ID=10659677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59549/90A Ceased AU667796B2 (en) 1989-07-07 1990-07-06 Production of antigens by self-assembly of polypeptide components

Country Status (5)

Country Link
AU (1) AU667796B2 (en)
CA (1) CA2075896A1 (en)
GB (1) GB8915571D0 (en)
WO (1) WO1991000914A1 (en)
ZA (1) ZA905295B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169784A (en) * 1990-09-17 1992-12-08 The Texas A & M University System Baculovirus dual promoter expression vector
EP0749694A1 (en) 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Treatment enzymatic of cocoa
CN117801099B (en) * 2023-12-11 2024-08-30 中国农业科学院兰州兽医研究所 Recombinant monoclonal antibody of anti-bluetongue virus VP7 protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP114A (en) * 1987-02-19 1991-02-01 Oxford Virology Ltd Production of bluetongue virus antigens using a baculovirus expression vector.
IL87394A0 (en) * 1987-08-12 1989-12-15 Natural Environment Res Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing said vectors

Also Published As

Publication number Publication date
ZA905295B (en) 1991-03-27
WO1991000914A1 (en) 1991-01-24
AU667796B2 (en) 1996-04-18
GB8915571D0 (en) 1989-08-23
CA2075896A1 (en) 1991-01-08

Similar Documents

Publication Publication Date Title
AU5267190A (en) Modified antibodies
AU3101689A (en) Process for the preparation of cyclic sulphates
AU5793390A (en) Composition for producing bonded magnet
AU6092290A (en) Process for the recovery of gold
AU6036690A (en) Human monoclonal antibodies to hiv-1mn gp 120
AU6266090A (en) Process for the preparation of catalysts
HU896472D0 (en) Process for the preparation of novel benzopyramylpyrrolinone derivatives
AU5954990A (en) Production of antigens by self-assembly of polypeptide components
AU1704988A (en) Peptide production by protein engineering
AU2032788A (en) Process for the preparation of naphthacenes
GB2224258B (en) Process for the production of microspheres by crosslinking of proteins
AU7649187A (en) Preparation of monoclonal antibodies
AU1563188A (en) A process for the preparation of a genetically encodable polypeptide
AU3663789A (en) Process for the preparation of substituted anilides
AU3271089A (en) Process for the preparation of alkanediols
AU610736B2 (en) Process for the production of proteins
AU3136589A (en) Process for the preparation of alkanediols
AU2102888A (en) Process for the preparation of bisphenol-bisacrylates
AU7477687A (en) Initiation of antibody formation in vertebrates
AU5907190A (en) Preparation of polyacetals
AU6385886A (en) Production of ige-binding protein by recombinant methods
AU1994088A (en) Preparation of novel protein sweeteners-monellin type
AU4958690A (en) Preparation of 2-halofluorobenzene
AU2330488A (en) Improved method for the preparation of anilinofumarate
AU5913090A (en) A novel process for the preparation of 2-diazo-3- trisubstituted silyloxy-3-butenoates

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired